key: cord-0029456-7tsnqnle
authors: Lu, Fan; Gong, Han; Lei, Houkang; Li, Juan
title: Downregulation of cathepsin C alleviates endothelial cell dysfunction by suppressing p38 MAPK/NF-κB pathway in preeclampsia
date: 2022-01-17
journal: nan
DOI: 10.1080/21655979.2021.2023994
sha: c62624371faafb5603d28928840064292d4d8d13
doc_id: 29456
cord_uid: 7tsnqnle

Endothelial cell dysfunction is an essential pathophysiological feature of preeclampsia (PE). It has been reported that cathepsin C is upregulated in the maternal vascular endothelium of PE patients. The excessive activation of p38 MAPK leads to various diseases, including PE. NF-κB pathway can promote uteroplacental dysfunction, endothelial stress and development of PE. Moreover, it has been verified that cathepsin C can activate p38 MAPK/NF-κB pathway. In the present work, hypoxia/reoxygenation (H/R) injury model of HUVECs was established to discuss the biological functions of cathepsin C in endothelial cell dysfunction and to elucidate the underlying molecular mechanism. The correlation between cathepsin C and p38 MAPK/NF-κB pathway in H/R-stimulated HUVECs as well as the effects of cathepsin C and p38 MAPK/NF-κB pathway on viability, apoptosis, invasion, in vitro angiogenesis of HUVECs and oxidative stress were assessed. The results revealed that H/R injury elevated cathepsin C expression and activated p38 MAPK/NF-κB pathway in HUVECs and cathepsin C knockdown inhibited the activity of p38 MAPK/NF-κB pathway in H/R-stimulated HUVECs. Downregulation of cathepsin C improved viability, inhibited apoptosis and enhanced invasion of H/R-stimulated HUVECs. In addition, downregulation of cathepsin C alleviated oxidative stress and induced stronger HUVEC angiogenesis in vitro. Furthermore, the protective effects of cathepsin C knockdown against endothelial cell dysfunction were reversed by p38 MAPK activator anisomycin. In other words, downregulation of cathepsin C could improve HUVEC viability and enhance anti-apoptotic capacity, anti-oxidative capability, invasive ability, as well as angiogenic potential of H/R-stimulated HUVECs by repressing p38 MAPK/NF-κB pathway.

Preeclampsia (PE) is a multisystem progressive disease unique to pregnancy [1] . It is characterized by new-onset of hypertension and proteinuria after 20 weeks of gestation, or new-onset of hypertension and terminal organ dysfunction accompanied with or without proteinuria [2, 3] . PE seriously threatens the life safety of pregnant women and fetuses and is closely associated with maternal and fetal mortality worldwide [4] . Oxidative stress at the maternal-fetal interface, inflammation in maternal circulation and disturbance of angiogenesis are the main causes of PE [5] [6] [7] .

Cathepsin C (CatC), also known as dipeptidyl peptidase I (DPPI), is one of the cathepsins with lysosomal exo-cysteine protease activity [8] . Cathepsin C functions as a central coordinator for the activation of many serine proteases in immune cells [9] . Abnormal expression of cathepsin C may weaken the immune ability of organisms and induce infection and severe inflammation [10, 11] . Literature reports that cathepsin C is upregulated in the maternal vascular endothelium of PE patients [12] . However, the biological role of cathepsin C and specific mechanism underling the participation of cathepsin C in the progression of PE have not been fully elucidated till now.

p38 mitogen activated protein kinase (p38 MAPK) is a highly conserved member of the serine/threonine MAPK family whose primary function is to transmit extracellular signals to the cells [13] . p38 MAPK can regulate various pathophysiological processes, such as cell proliferation, differentiation, inflammation, oxidative stress and apoptosis [14, 15] . The excessive acti-vation or decreased expression of p38 MAPK leads to various diseases, including PE [16] . It has been verified that p38 MAPK signal pathway can regulate oxidative stress and apoptosis of endothelial cells and affect the angiogenic activity of extra villous trophoblast in PE [17] [18] [19] . Hence, p38 MAPK is expected to serve as a therapeutic target for PE.

Nuclear factor-kappaB (NF-κB), a common nuclear transcription factor, is widely present in the cytoplasm, and acts as a signaling pathway when cells are stimulated [20] . As a classic inflammation and oxidative stress signal pathway, NF-κB pathway plays an important role in the body's inflammatory response, immune regulation and apoptosis by regulating chemotactic cytokines, adhesion molecules, gene expressions of growth factors and various enzymes [21] [22] [23] . Importantly, it has been widely reported that NF-κB pathway can promote uteroplacental dysfunction, endothelial stress and development of PE [24, 25] . Thus, selective inhibition of NF-κB pathway may be an efficient approach for the treatment of PE.

To sum up, the correlation between cathepsin C and p38 MAPK/NF-κB pathway in H/ R-stimulated HUVECs as well as the effects of cathepsin C and p38 MAPK/NF-κB pathway on viability, apoptosis, invasion, in vitro angiogenesis of HUVECs and oxidative stress were assessed, aiming to discuss the biological functions of cathepsin C in endothelial cell dysfunction and to elucidate the underlying molecular mechanism.

Human umbilical vein endothelial cells (HUVECs) were purchased from the American Type Culture Collection (ATCC, VA, USA) and maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco, NY, USA) containing 10% fetal bovine serum (FBS; Gibco, NY, USA) and 1% penicillin/ streptomycin in a humidified incubator at 37°C with 5% CO 2 .

Cathepsin C siRNA and the control siRNA were obtained from GenePharma (Shanghai, China). For in vitro transfection, HUVECs were transfected with si-cathepsin C or si-NC using Lipofectamine 3000 (Invitrogen, CA, USA) for 48 h following the manufacturer's instructions.

To investigate the specific effects of p38 MAPK pathway, HUVECs were pre-incubated with or without p38 MAPK activator anisomycin (25 μg/ml; Cell Signaling Technology, MA, USA) for 30 min.

To establish H/R injury model of HUVECs, HUVECs were cultured in preconditioned hypoxic medium under 5% CO 2 and 95% N2 in a humidified incubator for 8 h and then replaced with a fresh medium. Afterward, HUVECs were cultured under normal growth conditions for 16 h of reoxygenation [26] .

The viability of the HUVECs was measured by CCK-8 assay. In short, HUVECs were cultured in 96-well plates (1 × 10 4 cells/well) for 24 h. Then, CCK-8 solution (Beyotime, Shanghai, China) was added into each well, and incubated for another 4 h. The absorbance was measured at 450 nm with a microplate reader (Bio-Rad, CA, USA).

The proportions of apoptotic cells were determined using FITC Annexin V Apoptosis Detection Kit (BD Bioscience, CA, USA). Briefly, HUVECs (1 × 10 6 ) were harvested and then washed twice with ice-cold PBS. Then, HUVECs were resuspended in 400 μl of 1× binding buffer, and cell suspension was incubated with Annexin V and PI in the dark for 15 min at room temperature. Next, HUVECs were assessed by a FACS flow cytometer (BD Biosciences, CA, USA).

HUVECs were harvested and washed with PBS. Next, HUVECs were incubated with the lysis buffer (Beyotime, Shanghai, China), and cell supernatant of lysates was collected by centrifugation. Levels of MDA and SOD were analyzed using MDA assay kit and SOD assay kit (Jiancheng Biotech, Nanjing, China).

HUVECs were resuspended in a serum-free medium and seeded onto the upper chamber of transwell chambers (Millipore, MA, USA) precoated Matrigel (BD Biosciences, CA, USA). Next, FBScontaining DMEM was placed to the lower chamber. After 24 h incubation, the invaded cells were fixed with 4% paraformaldehyde for 30 min and stained with 0.1% crystal violet (Solarbio, Beijing, China) for 30 min. The penetrated cells were photographed and counted under an inverted microscope (Nikon, Tokyo, Japan).

HUVECs were trypsinized, resuspended with a serum-free medium and seeded (2 × 10 4 cells/ well) into 96-well plates precoated with 50 μl Matrigel (BD Biosciences, CA, USA). After 24 h of incubation, tube formation was observed and photographed under an inverted microscope (Nikon, Tokyo, Japan). Quantitative analysis of tubules was performed using AngioSys 2.0 image analysis software (Cellworks, Buckingham, UK).

Total RNA was isolated from HUVECs using TRIzol reagent (Invitrogen, CA, USA) following the manufacturer's instructions. 1 µg RNA was reversely transcribed into cDNA using a reverse transcription kit (Takara, Tokyo, Japan). Next, PCR reactions were performed on ABI 7500 quantitative PCR instrument using SYBR Master Mixture (Takara, Tokyo, Japan). The PCR conditions were as follows: 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 60°C for 60 sec. The primers were as following: cathepsin C, forward: 5′-CCAACTGCACCTATCT TGACC −3′ and reverse: 5′-AAGGCAAACCA CTTGTAGTCATT −3′; GAPDH, forward: 5′-GAAGGTGAAGGTCGGAGTC −3′ and reverse: 5′-GAAGATGGTGATGGGATTTC −3′. The relative expression of mRNA was normalized to GAPDH and calculated using 2 -ΔΔCt method.

HUVECs were lysed in ice-cold RIPA lysis buffer (Beyotime, Shanghai, China), and protein concentration was measured by BCA Protein Assay Kit (Beyotime, Shanghai, China). Equal amounts of protein samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to PVDF membranes. Next, membranes were blocked with 5% BSA for 1 h at room temperature and then incubated overnight 4°C with the primary antibodies as follows: cathepsin C (Abcam, ab199109, 1:1000), p-p38 MAPK (Abcam, ab178867, 1:1000), p38 MAPK (Abcam, ab170099, 1:5000), p-NF-κB p65 (Abcam, ab76302, 1:1000), NF-κB p65 (Abcam, ab32536, 1:10,000), p-IκBα (Abcam, ab133462, 1:10,000), IκBα (Abcam, ab32518, 1:10,000), Bcl-2 (Abcam, ab196495, 1:2000), Bax (Abcam, ab53154, 1:1000), Birc5 (Abcam, ab76424, 1:5000), Cleaved PARP (Abcam, ab32064, 1:10,000), PARP (Abcam, ab191217, 1:1000) and GAPDH (Abcam, ab9485, 1:2500). On the second day, the membranes were incubated with the corresponding secondary antibody (Abcam, ab205718, 1:50,000) for 1.5 h at room temperature. Protein blots were visualized using electrochemiluminescence (ECL; Beyotime, Shanghai, China) method and analyzed by a Bio-Rad imaging system (Bio-Rad, CA, USA).

Each experiment is performed in triplicate. Experimental data were analyzed by one-way analysis of variance (ANOVA) followed by Tukey's post hoc test using GraphPad Prism 7.00 and expressed as mean ± standard deviation. Differences in statistical significance were set at p < 0.05. *p < 0.05, **p < 0.01, ***p < 0.001

The biological roles of cathepsin C and p38 MAPK/NF-κB pathway in H/R injury model of HUVECs were evaluated. H/R injury enhanced cathepsin C expression in HUVECs (Figure 1(a) ). Besides, elevated expressions of p-p38 MAPK, p-NF-κB p65 and p-IκBα evidenced that p38 MAPK/NF-κB pathway was activated in H/ R-stimulated HUVECs (Figure 1(b) ).

To elucidate the correlation between cathepsin C and p38 MAPK/NF-κB pathway, H/R-stimulated HUVECs were transfected with si-cathepsin C-1 or sicathepsin C-2, and then the activity of p38 MAPK/ NF-κB pathway was assessed. Transfection with sicathepsin C-1 or si-cathepsin C-2 distinctly downregulated cathepsin C expression (Figure 2(a, b) ). Due to the optimized transfection efficiency, si-cathepsin C-1 was selected for subsequent analysis. Decreased expressions of p-p38 MAPK, p-NF-κB p65 and p-IκBα indicated that activation of p38 MAPK/NF-κB pathway in H/R-stimulated HUVECs was inhibited by downregulation of cathepsin C (Figure 2(c) ).

H/R injury led to decreased HUVEC viability and increased apoptosis of HUVECs. Downregulation of cathepsin C improved the viability of H/R-stimulated HUVECs, which was partially abrogated by treatment with p38 MAPK activator anisomycin (Figure 3(a) ). Moreover, downregulation of cathepsin C repressed apoptosis of H/R-stimulated HUVECs and anisomycin reversed the suppressing effects of cathepsin C knockdown on apoptosis of H/ R-stimulated HUVECs (Figure 3(b, c) ). Besides, decreased Bcl-2 expression and increased expressions of Bax, Birc5 and cleaved PARP were observed in H/ R-stimulated HUVECs. Downregulation of cathepsin C elevated Bcl-2 expression and reduced expressions of Bax, Birc5 and cleaved PARP, which were reversed upon anisomycin treatment (Figure 3(d) ). In other words, cathepsin C knockdown improved viability and suppressed apoptosis of H/R-stimulated HUVECs by repressing p38 MAPK/NF-κB pathway.

H/R injury increased the levels of MDA, OXSR1 and Nitrotyrosine as well as decreased the levels of SOD and p-eNOS in HUVECs. Downregulation of cathepsin C reduced the levels of MDA, OXSR1 and Nitrotyrosine as well as elevated the levels of SOD and p-eNOS in H/R-stimulated HUVECs. Furthermore, anisomycin treatment reversed the regulating effects of cathepsin C knockdown on the levels of oxidative stress associated markers (Figure 4(a, b) ). In summary, cathepsin C knockdown mitigated oxidative stress in H/ R-stimulated HUVECs by repressing p38 MAPK/ NF-κB pathway. were transfected with si-cathepsin C-1 or si-cathepsin C-2. Western blot assay was employed to detect cathepsin C protein expression to validate transfection efficiency. (b) HUVECs were transfected with si-cathepsin C-1 or si-cathepsin C-2. RT-qPCR was employed to detect cathepsin C mRNA level to validate transfection efficiency. (c) Western blot assay was employed to detect expressions of p-p38 MAPK, p38 MAPK, p-NF-κB p65, NF-κB p65, p-IκBα and IκBα. * p < 0.05, ** p < 0.01, *** p < 0.001.

Attenuated invasion of HUVECs was observed in H/R-stimulated HUVECs. Downregulation of cathepsin C enhanced invasion of H/R-stimulated HUVECs and the promoting effect of cathepsin C knockdown on invasion of HUVECs was partly abolished by anisomycin treatment (Figure 5(a, b) ).

Results of tube formation assay revealed that H/R injury resulted in a week in vitro angiogenesis in HUVECs. Downregulation of cathepsin C streng thened in vitro angiogenesis in H/R-stimulated HUVECs. The enhancing effect of cathepsin C knockdown on HUVEC angiogenesis in vitro was partially abrogated by anisomycin treatment (Figure 6(a, b) ).

It has been demonstrated that the main causes of PE include abnormal remodeling of spiral arteries in placenta, placental defects, oxidative stress at maternal-fetal interface, inflammation in maternal circulation and disturbance of angiogenesis. These events result in a systemic and diffuse endothelial cell dysfunction, an essential pathophysiological feature of PE [6, 7] .

Cathepsin C is a lysosomal cysteine protease belonging to the papain superfamily [8] . Cathepsin C can activate serine proteases and secrete serine proteases into the microenvironment to produce proinflammatory effects [27] . Nowadays, cathepsin C has received increasing attention due to its biological roles in various systemic diseases, such as tumor, osteoporosis and rheumatoid arthritis [28] [29] [30] . However, the specific role of cathepsin C in the progression of PE is rarely discussed. Gu et al. [12] report that cathepsin C is markedly upregulated in the maternal vascular endothelium of PE patients compared with normal pregnant controls. Besides, literature proves that cathepsin C is highly expressed in high glucose-treated HUVECs [31] . Researches above indicate that cathepsin C is closely associated with the occurrence and development of endothelial cell dysfunction. In this investigation, elevated cathepsin C expression was observed in H/R-stimulated HUVECs and H/R injury led to HUVEC dysfunction. Downregulation of cathepsin C improved HUVEC viability and enhanced anti-apoptotic capacity, anti-oxidative capability, invasive ability, as well as angiogenic potential of H/R-stimulated HUVECs, protecting against H/R-induced HUVEC dysfunction.

Previous reports indicate that p38 MAPK/NF-κB signaling pathway plays a vital role in PE progression. Zhao et al. [17] discover that H 2 O 2 treatment could promote p38 MAPK phosphorylation in HUVECs, while p38 MAPK inhibitor could restrain H 2 O 2induced apoptosis and alleviate PE-related endothelial cell injury. Kim et al. [24] report that NF-κB inhibitor or NF-κB p65 knockdown could downregulate miR-31-5p expression in human endothelial cells to suppress endothelial cell dysfunction of PE. Besides, researchers prove that cathepsin C could activate p38 MAPK/NF-κB pathway [32, 33] . In this present work, H/R injury activated p38 MAPK/NF-κB pathway in HUVECs and cathepsin C knockdown inhibited the activity of p38 MAPK/NF-κB pathway in H/R-stimulated HUVECs. Cathepsin C knockdown improved viability, inhibited apoptosis and enhanced invasion of H/R-stimulated HUVECs, alleviated oxidative stress as well as induced stronger HUVEC angiogenesis in vitro, which were reversed by anisomycin treatment.

To conclude, downregulation of cathepsin C improved HUVEC viability and enhanced antiapoptotic capacity, anti-oxidative capability, invasive ability, as well as angiogenic potential of H/ R-stimulated HUVECs by repressing p38 MAPK/ NF-κB pathway. The study on the protective mechanism of cathepsin C knockdown against endothelial cell dysfunction may suggest a novel promising approach for PE therapies.

All the authors designed the study, performed the experiments, analyzed the data, wrote the manuscript and revised the manuscript.

All authors approve of submitting the manuscript to your journal for publication.

The analyzed data sets generated during the present study are available from the corresponding authors on reasonable request.

No potential conflict of interest was reported by the author(s).

The author(s) reported that there is no funding associated with the work featured in this article.

Preeclampsia

The role of the renin-angiotensin-aldosterone system in preeclampsia: a review

Laminins regulate placentation and pre-eclampsia: focus on trophoblasts and endothelial cells

Prothrombotic state associated with preeclampsia

Epigenetic processes during preeclampsia and effects on fetal development and chronic health

Altered development and function of the placental regions in preeclampsia and its association with long-chain polyunsaturated fatty acids

Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia

Identification, expression, and responses to bacterial challenge of the cathepsin C gene from the razor clam sinonovacula constricta

Abrogation of cathepsin C by helicobacter pylori impairs neutrophil activation to promote gastric infection

lung protection by cathepsin c inhibition: a new hope for COVID-19 and ARDS

Characterization of cathepsin C from orange-spotted grouper, Epinephelus coioides involved in SGIV infection

Upregulation of cathepsin C expression contributes to endothelial chymase activation in preeclampsia

Roles of p38-MAPK in insulin resistant heart: evidence from bench to future bedside application

Oxidative stress promotes cellular damages in the cervix: implications for normal and pathologic cervical function in human pregnancydagger

Atorvastatin attenuates isoflurane-induced activation of ROS-p38MAPK/ATF2 pathway, neuronal degeneration, and cognitive impairment of the aged mice

siRNA-mediated NCAM1 gene silencing suppresses oxidative stress in pre-eclampsia by inhibiting the p38MAPK signaling pathway

Dysregulated expression of ACTN4 contributes to endothelial cell injury via the activation of the p38-MAPK/p53 apoptosis pathway in preeclampsia

Alpha-1-antitrypsin suppresses oxidative stress in preeclampsia by inhibiting the p38MAPK signaling pathway: an in vivo and in vitro study

Restraint of trophoblast invasion of the uterus by decorin: role in pre-eclampsia

Apocynin inhibits placental TLR4/NF-kappaB signaling pathway and ameliorates preeclampsia-like symptoms in rats

NF-kappaB in gastric cancer development and therapy

Nuclear factor-kappa B and its role in inflammatory lung disease

the nuclear factor kappa B (NF-kB) signaling in cancer development and immune diseases

NF-kappaB-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase

The role of nf kappab in healthy and preeclamptic placenta: trophoblasts in the spotlight

1-O-hexyl-2,3,5-trimethylhydroquinone ameliorates the development of preeclampsia through suppression of oxidative stress and endothelial cell apoptosis

Therapeutic targeting of cathepsin C: from pathophysiology to treatment

Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation

Intracellular cathepsin C levels determine sensitivity of cells to leucyl-leucine methyl ester-triggered apoptosis

Up-regulated cathepsin C induces macrophage M1 polarization through FAK-triggered p38 MAPK/NF-kappaB pathway

Structurebased design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C

Lysosome-membrane fusion mediated superoxide production in hyperglycaemia-induced endothelial dysfunction

Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca(2+)-dependent PKC/ p38MAPK/NF-kappaB pathway